| Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 |
|---|---|---|---|---|---|---|---|---|---|
Net sales | |||||||||
1,417,536 | 1,337,991 | 1,280,986 | 1,344,777 | 1,301,984 | 1,254,456 | 1,169,747 | 1,087,431 | 1,009,825 | 892,975 |
Cost of sales | |||||||||
494,975 | 493,338 | 454,328 | 479,570 | 486,494 | 430,432 | 419,938 | 371,869 | 342,752 | 293,285 |
Gross profit | |||||||||
922,561 | 844,653 | 826,658 | 865,207 | 815,490 | 824,024 | 749,809 | 715,562 | 667,073 | 599,690 |
Operating expenses: | |||||||||
Research and development | |||||||||
154,084 | 149,841 | 146,830 | 163,666 | 146,070 | 122,476 | 130,636 | 126,040 | 107,900 | 97,331 |
Sales and marketing | |||||||||
375,562 | 376,321 | 359,598 | 376,141 | 371,523 | 343,549 | 307,332 | 267,484 | 244,814 | 227,408 |
General and administrative, restructuring, integration and other | |||||||||
200,098 | 180,573 | 102,066 | 126,637 | 199,072 | 152,068 | 185,507 | 110,009 | 115,933 | 113,936 |
Acquisition-related intangible amortization | |||||||||
39,398 | 39,091 | 38,666 | 37,070 | 35,495 | 36,117 | 26,746 | 23,492 | 18,221 | 14,368 |
Purchased in-process research and development | |||||||||
- | - | - | - | - | - | - | - | - | 985 |
Total operating expenses | |||||||||
769,142 | 745,826 | 647,160 | 703,514 | 752,160 | 654,210 | 650,221 | 527,025 | 486,868 | 454,028 |
Income from operations | |||||||||
153,419 | 98,827 | 179,498 | 161,693 | 63,330 | 169,814 | 99,588 | 188,537 | 180,205 | 145,662 |
Other income (expense): | |||||||||
Interest income | |||||||||
10,645 | 6,776 | 4,753 | 3,964 | 2,299 | 2,382 | 6,128 | 4,457 | 3,522 | 9,511 |
Interest expense | |||||||||
49,685 | 39,022 | 37,396 | 39,330 | 30,882 | 23,452 | 25,358 | 27,815 | 29,641 | 37,527 |
Other expense, net | |||||||||
-4 | -9,673 | -10,552 | -6,938 | 2,591 | -3,591 | 15,854 | 7,942 | 18,244 | 1,640 |
Total other expense, net | |||||||||
-39,044 | -41,919 | -43,195 | -42,304 | -25,992 | -24,661 | -3,376 | -15,416 | -7,875 | -26,376 |
Income before income taxes | |||||||||
114,375 | 56,908 | 136,303 | 119,389 | 37,338 | 145,153 | 96,212 | 173,121 | 172,330 | 119,286 |
Income taxes | |||||||||
73,981 | -23,395 | 6,401 | 2,456 | -31,760 | 15,616 | 1,263 | 28,810 | 34,563 | 29,762 |
Net income | |||||||||
40,394 | 80,303 | 129,902 | 116,933 | 69,098 | 129,537 | 94,949 | 144,311 | 137,767 | 89,524 |
Net loss attributable to noncontrolling interest | |||||||||
0 | -101 | -246 | 568 | 25 | 31 | -1,089 | 0 | 0 | 491 |
Net income attributable to the owners of QIAGEN N.V. | |||||||||
40,394 | 80,404 | 130,148 | 116,365 | 69,073 | 129,506 | 96,038 | 144,311 | 137,767 | 89,033 |
Basic net income per common share attributable to the owners of QIAGEN N.V. (in USD per share) | |||||||||
0.18 | 0.34 | 0.56 | 0.50 | 0.30 | 0.55 | 0.41 | 0.62 | 0.67 | 0.45 |
Diluted net income per common share attributable to the owners of QIAGEN N.V. (in USD per share) | |||||||||
0.17 | 0.34 | 0.55 | 0.48 | 0.29 | 0.54 | 0.40 | 0.60 | 0.64 | 0.44 |
Weighted-average common shares outstanding | |||||||||
Basic (in shares) | |||||||||
228,074 | 234,800 | 233,483 | 232,644 | 234,000 | 235,582 | 233,850 | 232,635 | 206,928 | 196,804 |
Diluted (in shares) | |||||||||
233,009 | 238,993 | 238,647 | 242,806 | 242,175 | 240,746 | 239,064 | 240,483 | 213,612 | 204,259 |